Pioglitazone enhances splanchnic glucose uptake as well as peripheral glucose uptake in non-insulin-dependent diabetes mellitus
- 1 July 1998
- journal article
- clinical trial
- Published by Elsevier in Diabetes Research and Clinical Practice
- Vol. 41 (1) , 35-43
- https://doi.org/10.1016/s0168-8227(98)00056-4
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- The effect of pioglitazone on hepatic glucose uptake measured with indirect and direct methods in alloxan-induced diabetic dogsDiabetes, 1997
- A noninvasive method to measure splanchnic glucose uptake after oral glucose administration.Journal of Clinical Investigation, 1995
- Pioglitazone Ameliorates High Glucose Induced Desensitization of Insulin Receptor Kinase in Rat 1 Fibroblasts in CultureBiochemical and Biophysical Research Communications, 1993
- Hormonal responses and future treatment of non‐insulin‐dependent diabetes mellitus (NIDDM)*Journal of Internal Medicine, 1993
- Early Metabolic Defects in Persons at Increased Risk for Non-Insulin-Dependent Diabetes MellitusNew England Journal of Medicine, 1989
- Absorption of an Oral Glucose Load in the DogHormone and Metabolic Research, 1986
- Enhancement of insulin action after oral glucose ingestion.Journal of Clinical Investigation, 1986
- The effect of insulin treatment on insulin secretion and insulin action in type II diabetes mellitusDiabetes, 1985
- Insulin therapy in obese, non-insulin-dependent diabetes induces improvements in insulin action and secretion that are maintained for two weeks after insulin withdrawalDiabetes, 1984
- Insulin production rate following glucose ingestion estimated by splanchnic C-peptide output in normal manDiabetologia, 1979